Company news
Laboratorios Farmaceuticos Rovi, S.a. (BME:ROVI) news
Every Laboratorios Farmaceuticos Rovi, S.a. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Laboratorios Farmaceuticos Rovi S A : First half 2026 results press release
July 23, 2026
Laboratorios Farmaceuticos Rovi S A : ROVI and the Regional Government of Castilla-La Mancha promote a framework of collaboration to modernise healthcare services through technological innovation
July 8, 2026
Laboratorios Farmaceuticos Rovi S A : First three months of 2026 results press release
May 6, 2026
Laboratorios Farmaceuticos Rovi S A : 2025 results press release
February 25, 2026
Laboratorios Farmaceuticos Rovi S A : ROVI releases the press release in relation to the signing of the definitive collaboration agreement with Roche for the manufacture of a new medicine in development
November 18, 2025
Laboratorios Farmaceuticos Rovi S A : First nine months of 2025 results press release
November 6, 2025
Laboratorios Farmaceuticos Rovi S A : ROVI announces a collaboration with Roche for the manufacture of a new medicine in development
October 21, 2025
Laboratorios Farmaceuticos Rovi S A : ROVI announces the acquisition of an injectable drug product manufacturing site in Phoenix, Arizona (USA)
September 29, 2025
Laboratorios Farmaceuticos Rovi S A : First half 2025 results press release
July 24, 2025
Laboratorios Farmaceuticos Rovi S A : ROVI held its 2025 General Shareholders’ Meeting
June 18, 2025
Laboratorios Farmaceuticos Rovi S A : First three months 2025 results press release
May 8, 2025
Laboratorios Farmaceuticos Rovi S A : 2025 Capital Markets Day presentation
March 25, 2025
Laboratorios Farmaceuticos Rovi S A : 2024 results press release
February 25, 2025
Laboratorios Farmaceuticos Rovi S A : First nine months 2024 results press release
November 7, 2024
Laboratorios Farmaceuticos Rovi S A : ROVI completes the strategic review of its CDMO business
October 24, 2024
Laboratorios Farmaceuticos Rovi S A : First half 2024 results press release
July 31, 2024
Laboratorios Farmaceuticos Rovi S A : ROVI invests 60 million euros to expand the production capacity of its San Sebastián de los Reyes plant by 31.5%
July 11, 2024
Laboratorios Farmaceuticos Rovi S A : ROVI forecasts potential Risperidone ISM® sales of between 200 and 300 million euros globally in upcoming years
June 24, 2024
Laboratorios Farmaceuticos Rovi S A : ROVI completes its new Escúzar plant by including a sodium heparin production facility
June 20, 2024
Laboratorios Farmaceuticos Rovi S A : First three months 2024 results press release
May 8, 2024
Laboratorios Farmaceuticos Rovi S A : ROVI announces agreement to manufacture pre-filled syringes
April 25, 2024
Laboratorios Farmaceuticos Rovi S A : ROVI, Insud Pharma and Innvierte (CDTI) create a company for the research and development of advanced therapies
March 12, 2024
Laboratorios Farmaceuticos Rovi S A : First nine months 2023 results press release
November 10, 2023
Laboratorios Farmaceuticos Rovi S A : ROVI informs on the evaluation process to obtain marketing authorisation for Risvan®
July 28, 2023
Laboratorios Farmaceuticos Rovi S A : First half 2023 results press release
July 26, 2023
Laboratorios Farmaceuticos Rovi S A : First quarter 2023 results press release
May 10, 2023